Protective immunity against equine herpesvirus type-1 (EHV-1) infection in mice induced by recombinant EHV-1 gD

Virus Research

Volumn 56, Issue 1, 1998, Pages 11-24

  Zhang, Yunfei ^a   Smith, Patrick M ^a   Tarbet, E Bart ^a,c   Osterrieder, Nikolaus ^a,b   Jennings, Stephen R ^a   O'Callaghan, Dennis J ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c MERCK ANIMAL HEALTH   (United States)

Author keywords

Equine herpesvirus 1; Mouse model; Recombinant gD; Vaccine

Indexed keywords

GLUTATHIONE TRANSFERASE; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLONING, MOLECULAR; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HORSES; MICE; MICE, INBRED BALB C; RESPIRATORY TRACT INFECTIONS; VACCINATION; VIRAL FUSION PROTEINS;

EQUIDAE; EQUINE HERPESVIRUS 1; ESCHERICHIA COLI; HERPESVIRIDAE; HERPESVIRUS 1;

EID: 0032128204     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(98)00054-9     Document Type: Article

References (55)

1. Allen, G.P., Bryans, J.T., 1986. Molecular epizootiology, pathogenesis and prophylaxis of equine herpesvirus type 1 infections. In: Pandey, R. (Ed.), Progress in Veterinary Microbiology and Immunology, Vol. 2. Karger, Basel, pp. 78-144.
2. Allen G., Yeargan M., Costa L.R., Cross R. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1. J. Virol. 69:1995;606-612.
3. Awan A.R., Chong Y.C., Field H.J. The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J. Gen. Virol. 71:1990;1131-1140.
4. Awan A.R., Gibson J.S., Field H.J. A murine model for studying EHV-1 induced abortion. Res. Vet. Sci. 51:1991;94-99.
5. Azmi M., Field H.J. Cell-mediated antiviral response to equine herpesvirus type 1 demonstrated in a murine infection model by means of adoptive transfer of immune cells. J. Gen. Virol. 74:1993;275-280.
6. Blacklaws B.A., Krishna S., Minson A.C., Nash A.A. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology. 177:1990;727-736.
7. Brehm M.A., Bonneau R.H., Knipe D.M., Tevethia S.S. Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1. J. Virol. 71:1997;3534-3544.
8. Burki F., Rofsmanith W., Nowotny N., Pallan C., Mostl K., Lussy H. Viremia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Vet. Quarter. 12:1990;80-86.
9. Burrows R., Goodridge D., Denyer M.S. Trials of an inactivated equid herpesvirus-1 vaccine: challenge with a subtype-1 virus. Vet. Res. 114:1984;369-374.
10. Ceredig R., Lowenthal J.W., Nabholz M., MacDonald H.R. Expression of IL-2 receptors as differentiation markers on intrathymic stem cells. Nature (London). 314:1985;98-100.
11. Cohen G.H., Muggeridge M.I., Long D., Sodora D.A., Eisenberg R.J. Structural and functional studies of herpes simplex virus glycoprotein D. Adv. Exp. Med. Biol. 327:1992;217-228.
12. Colle III C.F., O'Callaghan D.J. Transcriptional analyses of the unique short segment of EHV-1 strain Kentucky A. Virus Genes. 9:1995;257-268.
13. Colle III C.F., Tarbet E.B., Grafton W.D., Jennings S.R., O'Callaghan D.J. Equine herpesvirus-1 strain KyA, a candidate vaccine strain, reduces viral titers in mice challenged with a pathogenic strain. RacL. Virus Res. 43:1996;111-124.
14. Crabb B.S., Studdert M.J. Equine herpesvirus 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Adv. Virus Res. 45:1995;153-190.
15. DaCosta X.J., Bourne N., Stanberry L.R., Knipe D.M. Construction and characterization of a replication-defective herpes simplex virus 2 ICP8 mutant strain and its use in immunization studies in a guinea pig model of genital disease. Virology. 232:1997;1-12.
16. Douce, G., Dougan, G., Pizza, M., Rappuoli, R., Roberts, M., 1997. Mutant pertussis and Escherichia coli heat-labile toxins as adjuvants for enhancing local and systemic immune responses to coadministered, nonliving antigens. In: Levine, M.M., Woodrow, G.C., Kaper, J.B., Cobon, G.S. (Eds.), New Generation Vaccines, 2nd edn. Marcel Dekker, Inc., New York, pp. 253-262.
17. Flowers C.C., O'Callaghan D.J. Equine herpesvirus 1 glycoprotein D: mapping of the transcript and a neutralization epitope. J. Virol. 66:1992;6451-6460.
18. Flowers C.C., O'Callaghan D.J. The equine herpesvirus type 1 (EHV-1) homolog of herpes simplex virus type 1 US9 and the nature of a major deletion within the unique short segment of the EHV-1 KyA strain genome. Virology. 190:1992;307-315.
19. Flowers C.C., Flowers S.P., Jennings S.R., O'Callaghan D.J. Synthesis and processing of equine herpesvirus 1 glycoprotein D. Virology. 208:1995;9-18.
20. Flowers C.C., Flowers S.P., Sheng Y., Tarbet E.B., Jennings S.R., O'Callaghan D.J. Expression of membrane-bound and secreted forms of equine herpesvirus 1 glycoprotein D by recombinant baculovirus. Virus Res. 35:1995;17-34.
21. b CTL effectors and precursors specific for the SV40 transplantation rejection antigen. J. Immunol. 129:1982;2368-2371.
22. Gleeson L.J., Coggins L. Response of pregnant mares to equine herpesvirus 1 (EHV1). Cornell Veterinarian. 70:1980;391-400.
23. Grandell R.A., Mock R.A., Lock T.F. Vaccination of pregnant ponies against equine rhinopneumonitis. Am. J. Vet. Res. 41:1980;994-996.
24. Hannant D., Jessett D.M., O'Neill T., Dolby C.A., Cook R.F., Mumford J.A. Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain. Res. Vet. Sci. 54:1993;299-305.
25. Hubert P.H., Birkenmaier S., Rziha H.J., Osterrieder N. Alterations in the equine herpesvirus type-1 (EHV-1) strain RacH during attenuation. Zentralbl. Veterinarmed. Reihe B. 43:1996;1-14.
26. Jennings S.R., Bonneau R.H., Smith P.M., Wolcott R.M., Chervenak R. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice. Cell. Immunol. 133:1991;234-252.
27. Kim S.K., Smith R.H., O'Callaghan D.J. Characterization of DNA binding properties of the immediate-early gene product of equine herpesvirus type 1. Virology. 213:1995;46-56.
28. Kohl S. The role of antibody in herpes simplex virus infection in humans. Curr. Top. Microbiol. Immunol. 179:1992;75-88.
29. Krishna S., Blacklaws B.A., Overton H.A., Bishop D.H., Nash A.A. Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts. J. Gen. Virol. 70:1989;1805-1814.
30. Kruisbeek, A.M., Shevach, E., 1997. Proliferative assays for T cell function. In: Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., Strober, W. (Eds.), Current Protocols in Immunology (CD-ROM). Wiley, New York, Unit 3.12.
31. Laemmli U.K. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature (London). 227:1970;680-685.
32. Love D.N., Bell C.W., Pye D., Edwards S., Hayden M., Lawrence G.L., Boyle D., Pye T., Whalley J.M. Expression of equine herpesvirus 1 glycoprotein D by using a recombinant baculovirus. J. Virol. 67:1993;6820-6823.
33. Mackay C.R., Andrew D.P., Briskin M., Ringler D.J., Butcher E.C. Phenotype, and migration properties of three major subsets of tissue homing T cells in sheep. Eur. J. Immunol. 26:1996;2433-2439.
34. Morrison L.A., Knipe D.M. Mechanisms of immunization with a replication-defective mutant of herpes simplex virus 1. Virology. 220:1996;402-413.
35. Muggeridge M.I., Wu T.T., Johnson D.C., Glorioso J.C., Eisenberg R.J., Cohen G.H. Antigenic and functional analysis of a neutralization site of HSV-1 glycoprotein D. Virology. 174:1990;375-387.
36. O'Callaghan, D.J., Osterrieder, N., 1998. The Equine Herpesviruses. In: Webster, R.G., Granoff, A. (Eds.), Encyclopedia Of Virology, Volume Two. Academic Press, Harcourt Brace and Company, New York, In Press.
37. Onions D. Equine herpesviruses: New approaches to an old problem. Equine Vet. J. 23(1):1991;6-7.
38. Osterrieder N., Wagner R., Brandmuller C., Neubauer A., Schmidt P., Wolf H., Kaaden O.R. Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB). Virology. 208:1995;500-510.
39. Osterrieder N., Holden V.R., Brandmuller C., Neubauer A., Kaaden O.R., O'Callaghan D.J. The equine herpesvirus 1 IR6 protein is nonessential for virus growth in vitro and modified by serial virus passage in cell culture. Virology. 217:1996;442-451.
40. Osterrieder N., Neubauer A., Brandmuller C., Kaaden O.-R., O'Callaghan D.J. The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence. Virology. 226:1996;243-261.
41. Perdue M.L., Kemp M.C., Randall C.C., O'Callaghan D.J. Studies of the molecular anatomy of the L-M cell strain of equine herpesvirus type l. Proteins of the nucleocapsid and intact virion. Virology. 59:1974;201-216.
42. Raulet D.H., Gottleib P.D., Bevan M.J. Fractionation of lymphocyte populations with monoclonal antibodies specific for Lyt 2.2 and Lyt 3.1. J. Immunol. 125:1980;1136-1143.
43. Schmid D.S., Rouse B.T. The role of T cell immunity in control of herpes simplex virus. Curr. Top. Microbiol. Immunol. 179:1992;57-74.
44. Simmons A., Nash A.A. Role of antibody in primary and recurrent herpes simplex infections. J. Virol. 53:1985;944-948.
45. Smith D.B., Johnson K.S. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 67:1988;31-40.
46. Smith P.M., Wolcott R.M., Chervenak R., Jennings S.R. Control of cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon- (IFN-). Virology. 202:1994;76-88.
47. Smith, P.M., Zhang, Y., Jennings, S.R., O'Callaghan.D.J., 1998. Characterization of the cytolytic T lymphocyte (CTL) response to a candidate vaccine strain of equine herpesvirus type 1 (EHV-1) in CBA mice. J. Virol. 72, 5366-5372.
48. k) murine model. Virus Res. 50:1997;159-173.
49. Summers, M.D., Smith, G.E., 1987. A manual of methods for baculovirus vectors and insect culture procedures. Texas Agricultural Experimental Station and Texas A&M University, College Station.
50. Telford E.A.R., Watson M.S., McBride K., Davison A.J. The DNA sequence of equine herpesvirus-1. Virology. 189:1992;304-316.
51. Tewari D., Whalley J.M., Love D.N., Field H.J. Characterization of immune responses to baculovirus-expressed equine herpesvirus type 1 glycoproteins D and H in a murine model. J. Gen. Virol. 75:1994;1735-1741.
52. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
53. van Woensel P.A.M., Goovarts D., Marx D., Visser N. A mouse model for testing the pathogenicity of equine herpesvirus-1 strains. J. Virol. Methods. 54:1995;39-49.
54. Wellington J.E., Lawrence G.L., Love D.N., Whalley J.M. Expression and characterization of equine herpesvirus 1 glycoprotein D in mammalian cell lines. Arch. Virol. 141:1996;1785-1793.
55. Whittaker G.R., Taylor L.A., Elton D.M., Giles L.E., Bonass W.A., Halliburton I.W., Killington R.A., Meredith D.M. Glycoprotein 60 of equine herpesvirus type 1 is a homologue of herpes simplex virus glycoprotein D and plays a major role in penetration of cells. J. Gen. Virol. 73:1992;801-809.